“Health authorities should make sure to prohibit all pharmacists from compounding medication without a doctor’s specific instructions,” the organization said in a statement.
However, the Korean Pharmaceutical Association said the KMA’s claims are groundless. They say doctors are deliberately shifting blame to pharmacists so that they will not themselves be held responsible for having prescribed drugs containing Valsartan.
Under the current system, the organization said, most pharmacists follow prescriptions, and cases of pharmacists replacing brand name drugs with generic drugs against the prescription are very rare.
“It only accounts for 1 percent of all issued prescriptions,” the organization said.